Mometasona Furoato Alter Genéricos (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Furoato Alter Genéricos, is a corticosteroid presented as a nasal spray for intranasal use. It is employed to manage inflammation of the nasal passages in conditions such as allergic rhinitis and nasal polyposis, providing symptom relief for adults and children when prescribed by a healthcare professional.

GNH USA supplies Mometasona Furoato Alter Genéricos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and offers reliable global distribution.

Mometasone furoate nasal spray is indicated for inflammatory conditions of the nasal mucosa, primarily within the allergic rhinitis and nasal polyp therapeutic areas. - Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea associated with seasonal or perennial allergens. - Nasal polyps: diminishes polyp size and improves nasal airflow after surgical removal or in chronic cases. - Non‑allergic rhinitis: alleviates nasal symptoms caused by irritants or vasomotor instability when other treatments are insufficient.

Mometasone furoate nasal spray may cause local and systemic adverse reactions, most of which are mild and reversible. Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Sore throat - Cough - Altered taste perception Serious or Rare Side Effects: - Severe or persistent nosebleeds - Nasal septum perforation - Visual disturbances or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal cavity - Anaphylactic or severe allergic reactions

Before using mometasone furoate nasal spray, consider the following precautions to ensure safe and effective therapy. - Pregnancy: consult a healthcare provider before initiating therapy - Children: use only as prescribed and monitor for growth effects - Recent nasal surgery or trauma: avoid use until healing is confirmed - Concurrent systemic corticosteroids: assess risk of systemic glucocorticoid exposure - Long‑term use: periodically evaluate for adrenal suppression or ocular effects - Store at room temperature: keep in the original container, protect from moisture and heat

Mometasone furoate nasal spray can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes. Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local exposure and side‑effect risk - Live vaccines: potential reduction in vaccine efficacy Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., fluconazole) - Macrolide antibiotics (e.g., erythromycin) - Protease inhibitors (e.g., ritonavir) - Antiretroviral agents that affect CYP3A4